Skip to main content
. 2023 Jan 20;8:1. doi: 10.1038/s41525-022-00346-5

Fig. 2. Overall survival (OS) among 18 patients with pancreatic cancer who received matched therapy.

Fig. 2

a OS in 18 patients. b OS in 5 patients who received targeted therapy as first line versus 13 patients who received it as ≥2nd line. c OS in 11 patients with matching score ≥50% versus 7 patients with matching score <50%. CI confidence interval, OS overall survival.